Inquire About a Product| Product: | (+/-)-Warfarin-d5 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Catalog Number: | D14593 | ||||||||
| CAS Number: | 75472-93-4 | ||||||||
| Synonyms: |
3-(α-Acetonylbenzyl)-4-hydroxycoumarin-d5; 4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-1-benzopyran-2-one-d5 |
||||||||
| Pricing: |
|
||||||||
| Formula: | C19D5H11O4 | ||||||||
| Enrichment: | 99% D | ||||||||
| Molecular Weight: | 313.36 | ||||||||
| Structure: |
|
||||||||
| Appearance: | White solid | ||||||||
| Category: | All Inhibitors | ||||||||
| Stability: | Stable under recommended storage conditions | ||||||||
| Storage: |
Store at room temperature. Adequate ventilation |
||||||||
| Transportation: |
IATA: Hazard Class: 6.1; UN Number: UN2811; Packing Group: I; Shipping Name: Toxic solid, organic, n.o.s. (Warfarin) |
||||||||
| Literature References: |
Holford, NH, Clinical Pharmacokinetics and Pharmacodynamics of Warfarin Understanding the Dose-Effect Relationship. Clinical Pharamacokinetics, 1986, 11 (6): 483–504.; Ansell J, Hirsh J, Hylek E et al., Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians evidence-based clinical practice guidelines (8th Edition). Chest, 2008, 133 (6 Suppl): 160S–198S. |
||||||||
| MSDS: | |||||||||
| Description: | A labeled anticoagulant. Used to prevent thrombosis and thromboembolism. Inhibits vitamin K epoxide reductase. Antagonizes vitamin K1 recycling, depleting active vitamin K1. |